Keywords
Delayed ejaculation, alexithymia, TAS
Delayed ejaculation, alexithymia, TAS
Upon the recommendation of referees Nelson Bennett and Salvatore Caruso, we have provided additional data that show the relationship between the three subfactors of TAS 20 and delayed ejaculation, including the results of the Spearmans Rho correlations we have done. We also have updated the data-set with the scores for the subfactors and the total scores of TAS 20.
Upon the recommendation of referees Nelson Bennett and Salvatore Caruso, we have provided additional data that show the relationship between the three subfactors of TAS 20 and delayed ejaculation, including the results of the Spearmans Rho correlations we have done. We also have updated the data-set with the scores for the subfactors and the total scores of TAS 20.
See the authors' detailed response to the review by Nelson Bennett
See the authors' detailed response to the review by Salvatore Caruso
Delayed Ejaculation (DE) is probably the least studied and understood of the Male Sexual Dysfunctions (MSD)1. However, its negative impact is significant as it typically results in lack of sexual fulfilment for both the man and his partner; the problem is further increased when procreation is among the couple’s goals of sexual intercourse. The terms delayed, retarded, inadequate or inhibited ejaculation, idiopathic anejaculation (inability to ejaculate) and psychogenic anejaculation have all been used synonymously to describe a delay or absence of male orgasm2. The Diagnostic and Statistical Manual of Mental Disorders -IV-TR3 defines DE as:
“the persistent or recurrent delay in, or absence of, orgasm after a normal sexual excitement phase during sexual activity that the clinician, taking into account the person’s age, judges to be adequate in focus, intensity, and duration. The disturbance causes marked distress or interpersonal difficulty”.
In the literature DE is reported to have an incidence rate between 3% and almost 40%, depending on age and comorbidities4–8. The essential medical causes of this problem include neurogenic, infective, endocrine and medication factors9. Psychological and interpersonal aspects are also involved in the onset and maintenance of DE, but there is little unanimity concerning these causes1.
Previous studies have found that Hypoactive Sexual Desire Disorder (HSDD), Erectile Dysfunction (ED) and Premature Ejaculation (PE) are strongly correlated with alexithymia10–14. Alexithymia (from the ancient Greek “a” for lack, “lexis” for word, and “thymos” for emotion) is a multifaceted personality construct introduced in the early 1970s by Nemiah and Sifneos15,16. The alexithymia construct describes a set of deficits in the cognitive processing of emotions, or more generally, a disturbance in the regulation of emotions17. The personality features that characterize alexithymic individuals include difficulty in identifying emotions and differentiating between emotions and the bodily sensations of emotional arousal; difficulty in communicating emotions to others; reduced imaginal and fantasy activity and an externally oriented cognitive style, a sub-factor of the alexithymia construct involving impoverished fantasy life, utilitarian thinking and a focus on external concrete data of the sensate environment18,19.
A deep analysis of the literature underlines that:
The aim of this study was to investigate the presence of alexithymia in men with DE and to correlate alexithymia levels with DE severity. According to specific features of the symptoms we hypothesize that alexithymia will not be associated with this specific sexual disorder. In fact, emotional control, an important clinical feature identified in DE conceptualization20,21, has been found to be negatively associated with alexithymia22,23.
60 outpatients with a diagnosis of DE assessed at the Institute of Clinical Sexology and at the Urology Department of Sapienza, University in Rome were enrolled in the study. DE was diagnosed after a specialist examination, i.e. a careful anamnesis and a physical examination, and according to DSM-IV-TR criteria.
Patients with previous and current psychotherapeutic experiences (6 patients) were not included because of the possible influence of psychotherapy on the degree of alexithymia19. Participants were informed in detail about the study, guaranteed confidentiality and anonymity and advised of their right to withdraw at any time. The ones who gave their consent to participate were provided with a research protocol including the following measures. The research protocol received institutional approval.
DE severity was evaluated using a self-reported Intravaginal Ejaculation Latency Time (IELT;24) measure. The participants were given the following options to categorise the latency time: 10–20 mins, 20–30 mins, 30–40 mins, 40–50 mins and ‘never reached orgasm’.
A questionnaire collecting demographic, anamnestic data and characteristics of the symptom (Lifelong or Acquired, Situational or Generalized DE) was filled by all patients. Alexithymia was measured by the 20-item Toronto Alexithymia Scale (TAS-20)25,26, a validated tool used to evaluate alexithymia levels. Even though alexithymia levels are measured on a continuous scale, different studies have established standard cut-off scores to distinguish alexithymic (TAS-20≥61) from non-alexithymic subjects (TAS-20≤51), with a borderline area for scores between 51 and 6119. The scale has a factor structure that reflects three separate, yet conceptually related, facets of the alexithymia construct25. The three factors are difficulty identifying feelings and distinguishing them from the somatic sensations that accompany emotional arousal (Subfactor 1), difficulty communicating feelings to other people (Subfactor 2) and externally oriented thinking (Subfactor 3).
Using SPSS version 19 (IBM-SPSS Inc., 2010, Chicago, IL, USA), descriptive analyses were run in order to check sample and symptom characteristics. The relationship between alexithymia level and DE severity was investigated by Spearman’s Rho correlation coefficient.
Table 1 shows the demographic characteristics of the respondents. The majority were in a relationship, employed, and had attended at least secondary school. Descriptive analysis (Table 2) revealed that the great majority of the patients presented a lifelong (73.3%) and generalized (90.6%) DE. Moreover, half of the patients declared that they had never reached orgasm, reporting that ejaculation was impossible. 81.4% of the sample was found to be non-alexithymic, with an overall average TAS-20 score of 45.46.
TAS scores did not significantly correlate with the severity of DE measured by IELT (p = 0.54). Total TAS scores and the scores of the three different subfactors did not significantly correlate with the severity of DE measured by IELT (respectively p = 0.54; p = 0.95; p = 0.47; p = 0.24).
Problems with “difficulty” in ejaculating may vary from a delay in the latency to ejaculation to a complete inability to ejaculate (anejaculation). According to the literature, we used the term Delayed Ejaculation (DE) to describe any and all ejaculatory disorders with either a long latency or absence of ejaculation3: our sample was composed of 50% of patients with delayed ejaculation and 50% that could not ejaculate. Furthermore, we found that 73.3% of the sample presented lifelong DE: this data is in strong contrast with the literature, where around 25% of patients suffer from lifelong DE, with the remainder reporting it as acquired7,27,28.
According to our hypothesis, the results show that the alexithymia construct does not seem to be correlated with DE (only 9.3% of the patients could be classified as alexithymics), in contrast to other MSDs, where this condition was found in about 30% of patients, specifically it was found in 23% for suffering from HSDD, in 25% of them with PE and 34% of the ones declaring to have ED10–13.
There is some evidence supporting the inadequacy of alexithymia as an etiological factor in DE pathogenesis. From the first psychodynamic interpretations, DE has been associated with obsessive traits20,21, in which emotional control has an important role. This hyper-control configuration in men presenting DE has also been strongly confirmed in our psychotherapeutic experience for this disorder. In the clinical setting it is very common that patients with DE present a wide range of control behaviours, which affect not only their sexual experience, but also their daily activities and relations. This control is indiscriminately projected over emotions, behaviour and thoughts. The presence of this control presumes that the person recognizes his emotional responses, a trait that is typically absent in subjects with alexithymia. Indeed alexithymia and emotional control were previously found to be negatively associated22,23. This finding could explain the low rates of alexithymic traits in our sample.
The lack of difficulty in identifying and communicating emotions to others in patients with DE may also be connected to the greater social acceptance of DE than Premature Ejaculation and Erectile Dysfunction: the symptom does not seem to affect core male identity. From a somatopsychic perspective, the consequent low individual and relational distress arising from DE conditions could represent an important protective factor from creating or exacerbating high levels of alexithymia.
More research is still necessary to understand and treat DE There is a strong need for more studies examining the precipitating and maintaining factors of this problem. Controlled and randomized outcome studies, using validated measures with sufficient follow-up periods, are necessary to determine the psychogenic variables connected with the onset and the maintenance of DE and the most efficacious methods of psychological treatment. The present studies are inadequate to make evidence-based recommendations about treatment1.
This paper can contribute to the understanding of DE by excluding one of the possible etiological factors that has been previously found to be important in the onset and the maintenance of other MSDs.
Written informed consent was obtained from all study participants before receiving the research protocol. Each subject was advised of own right to withdraw at any time.
RR, MG and SE conceived the study. CS designed the experiments. PMM, MG and SE carried out the research. RR and CS contributed to the design of experiments. MG and SE prepared the first draft of the manuscript. PMM, RR and CS contributed to the experimental design and preparation of the manuscript, supervising the study. All authors were involved in the revision of the draft manuscript and have agreed to the final content.
The present study was funded by the Department of Clinical and Dynamic Psychology, Faculty of Medicine and Psychology, Sapienza University of Rome (Code: C26A12K7SS).
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 2 (update) 20 May 13 |
read | read |
Version 1 07 Mar 13 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)